SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein

C Geng1,2, S Kaochar1,2, M Li1,2

  • 1Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

Oncogene
|April 18, 2017
PubMed

Insights

Speckle-type POZ protein (SPOP) loss in prostate cancer promotes cell proliferation by stabilizing c-MYC. This study identifies c-MYC as a direct SPOP substrate, explaining SPOP

Area of Science:

  • Oncology
  • Molecular Biology
  • Urology

Background:

  • Speckle-type POZ protein (SPOP) is frequently dysregulated in prostate adenocarcinoma (PC), suggesting a tumor suppressor role.
  • SPOP inactivation, through mutations or reduced mRNA, is linked to PC development.

Purpose of the Study:

  • To investigate the physiological role of SPOP in prostate epithelium in vivo.
  • To determine the molecular mechanism linking SPOP dysregulation to prostate cancer progression.

Main Methods:

  • Generated prostate-specific SPOP-ablated mice.
  • Assessed prostate mass, cell proliferation, and c-MYC expression.
  • Performed in vitro SPOP-c-MYC interaction and ubiquitination assays.
  • Analyzed transcriptomic data and patient cohorts for SPOP and c-MYC correlations.
  • Utilized organoid models for functional studies.

Main Results:

  • SPOP ablation in mice led to increased prostate mass, proliferation, and c-MYC levels, eventually causing prostatic intraepithelial neoplasia (PIN).
  • SPOP directly ubiquitinates and degrades c-MYC; this is impaired by PC-associated SPOP mutants.
  • Transcriptomic analysis revealed enrichment of c-MYC-driven genes in SPOP-mutated contexts, correlating with poor clinical outcomes in PC patients.
  • Spop-null prostate cells were more sensitive to c-MYC inhibition, confirming c-MYC's role in proliferation.

Conclusions:

  • SPOP is a key regulator of prostate luminal epithelial cell proliferation and c-MYC expression.
  • c-MYC is identified as a novel substrate of SPOP, and its stabilization upon SPOP inactivation is a mechanism contributing to PC.
  • SPOP dysregulation and subsequent c-MYC stabilization represent a significant pathway in prostate adenocarcinoma pathogenesis.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...